S-4 S-4 EX-FILING FEES 0001574235 Pulmatrix, Inc. N/A N/A 0001574235 2026-07-09 2026-07-09 0001574235 1 2026-07-09 2026-07-09 iso4217:USD xbrli:pure xbrli:shares

Calculation of Filing Fee Tables

S-4

Pulmatrix, Inc.

Table 1: Newly Registered and Carry Forward Securities ☐Not Applicable

Security Type

Security Class Title

Fee Calculation or Carry Forward Rule

Amount Registered

Proposed Maximum Offering Price Per Unit

Maximum Aggregate Offering Price

Fee Rate

Amount of Registration Fee

Carry Forward Form Type

Carry Forward File Number

Carry Forward Initial Effective Date

Filing Fee Previously Paid in Connection with Unsold Securities to be Carried Forward

Newly Registered Securities
Fees to be Paid 1 Equity Common Stock, $0.0001 par value per share Other 75,245,366 $ 752.45 0.0001381 $ 0.10
Fees Previously Paid
Carry Forward Securities
Carry Forward Securities

Total Offering Amounts:

$ 752.45

$ 0.10

Total Fees Previously Paid:

$ 0.00

Total Fee Offsets:

$ 0.00

Net Fee Due:

$ 0.10

Offering Note

1

Relates to common stock, $0.0001 par value per share, of Pulmatrix, Inc., a Delaware corporation ("Pulmatrix"), issuable to holders of common stock, $0.00001 par value per share, of Eos SENOLYTIX Inc., a Delaware corporation ("Eos"), in the proposed merger of PUOS Merger Sub, Inc., a Delaware corporation and a direct, wholly owned subsidiary of Pulmatrix, with and into Eos, with Eos surviving as the wholly owned subsidiary of Pulmatrix and the surviving corporation of the merger (the "Merger"). The amount of common stock of Pulmatrix to be registered includes the estimated maximum number of shares of common stock of Pulmatrix that are expected to be issued (or become issuable) pursuant to the Merger, without taking into account the effect of a reverse stock split of common stock of Pulmatrix, assuming an estimated pre-split exchange ratio (which is subject to adjustment prior to the closing of the Merger) of approximately 8.64 shares of common stock of Pulmatrix for each outstanding share of common stock of Eos. The amount registered additionally includes 10,000 shares of Pulmatrix common stock that may be issuable as a result of rounding up to the nearest share in lieu of issuing fractional shares. Estimated solely for purposes of calculating the registration fee in accordance with Rule 457(f)(2) of the U.S. Securities Act of 1933, as amended. Eos is a private company, no market exists for its securities, and it has an accumulated capital deficit. Therefore, the proposed maximum aggregate offering price for the shares expected to be issued pursuant to the Merger is one-third of the product of the par value of the Eos securities expected to be exchanged in the proposed merger.

Table 2: Fee Offset Claims and Sources ☑Not Applicable
Registrant or Filer Name Form or Filing Type File Number Initial Filing Date Filing Date Fee Offset Claimed Security Type Associated with Fee Offset Claimed Security Title Associated with Fee Offset Claimed Unsold Securities Associated with Fee Offset Claimed Unsold Aggregate Offering Amount Associated with Fee Offset Claimed Fee Paid with Fee Offset Source
Rules 457(b) and 0-11(a)(2)
Fee Offset Claims
Fee Offset Sources
Rule 457(p)
Fee Offset Claims
Fee Offset Sources
Table 3: Combined Prospectuses ☑Not Applicable

Security Type

Security Class Title

Amount of Securities Previously Registered

Maximum Aggregate Offering Price of Securities Previously Registered

Form Type

File Number

Initial Effective Date